Eurofins Scientific SE
Eurofins Scientific SE ERFSF Peers
See (ERFSF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ERFSF | $71.01 | -1.02% | 12.9B | 30.43 | $2.40 | +0.97% |
| LZAGY | $70.32 | -1.46% | 51.3B | 64.00 | $1.11 | +0.59% |
| LZAGF | $716.80 | +0.20% | 49.6B | 65.50 | $11.09 | +0.34% |
| WUXAY | $10.20 | -0.49% | 28.5B | 18.80 | $0.54 | +3.22% |
| WUXIF | $7.34 | +0.00% | 20.1B | 13.59 | $0.54 | +0.25% |
| BMXMF | $142.45 | +0.00% | 15.8B | 31.81 | $4.22 | +0.73% |
| SKHCF | $18.26 | +1.39% | 8.8B | 25.01 | $0.73 | +3.84% |
| SKHHY | $17.64 | -1.01% | 8.5B | 23.89 | $0.74 | +3.82% |
| DSRLF | $107.68 | +0.00% | 5.9B | 26.96 | $4.03 | +1.10% |
| HNGZY | $4.00 | +0.00% | 5.3B | 26.67 | $0.15 | +1.03% |
Stock Comparison
ERFSF vs LZAGY Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, LZAGY has a market cap of 51.3B. Regarding current trading prices, ERFSF is priced at $71.01, while LZAGY trades at $70.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas LZAGY's P/E ratio is 64.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to LZAGY's ROE of +0.06%. Regarding short-term risk, ERFSF is more volatile compared to LZAGY. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs LZAGF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, LZAGF has a market cap of 49.6B. Regarding current trading prices, ERFSF is priced at $71.01, while LZAGF trades at $716.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas LZAGF's P/E ratio is 65.50. In terms of profitability, ERFSF's ROE is +0.07%, compared to LZAGF's ROE of +0.06%. Regarding short-term risk, ERFSF is more volatile compared to LZAGF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs WUXAY Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, WUXAY has a market cap of 28.5B. Regarding current trading prices, ERFSF is priced at $71.01, while WUXAY trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas WUXAY's P/E ratio is 18.80. In terms of profitability, ERFSF's ROE is +0.07%, compared to WUXAY's ROE of +0.19%. Regarding short-term risk, ERFSF is more volatile compared to WUXAY. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs WUXIF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, WUXIF has a market cap of 20.1B. Regarding current trading prices, ERFSF is priced at $71.01, while WUXIF trades at $7.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas WUXIF's P/E ratio is 13.59. In terms of profitability, ERFSF's ROE is +0.07%, compared to WUXIF's ROE of +0.19%. Regarding short-term risk, ERFSF is more volatile compared to WUXIF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs BMXMF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, BMXMF has a market cap of 15.8B. Regarding current trading prices, ERFSF is priced at $71.01, while BMXMF trades at $142.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas BMXMF's P/E ratio is 31.81. In terms of profitability, ERFSF's ROE is +0.07%, compared to BMXMF's ROE of +0.10%. Regarding short-term risk, ERFSF is more volatile compared to BMXMF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs SKHCF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, SKHCF has a market cap of 8.8B. Regarding current trading prices, ERFSF is priced at $71.01, while SKHCF trades at $18.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas SKHCF's P/E ratio is 25.01. In terms of profitability, ERFSF's ROE is +0.07%, compared to SKHCF's ROE of +0.05%. Regarding short-term risk, ERFSF is more volatile compared to SKHCF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs SKHHY Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, SKHHY has a market cap of 8.5B. Regarding current trading prices, ERFSF is priced at $71.01, while SKHHY trades at $17.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas SKHHY's P/E ratio is 23.89. In terms of profitability, ERFSF's ROE is +0.07%, compared to SKHHY's ROE of +0.07%. Regarding short-term risk, ERFSF is less volatile compared to SKHHY. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs DSRLF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, DSRLF has a market cap of 5.9B. Regarding current trading prices, ERFSF is priced at $71.01, while DSRLF trades at $107.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas DSRLF's P/E ratio is 26.96. In terms of profitability, ERFSF's ROE is +0.07%, compared to DSRLF's ROE of +0.09%. Regarding short-term risk, ERFSF is more volatile compared to DSRLF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs HNGZY Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, HNGZY has a market cap of 5.3B. Regarding current trading prices, ERFSF is priced at $71.01, while HNGZY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas HNGZY's P/E ratio is 26.67. In terms of profitability, ERFSF's ROE is +0.07%, compared to HNGZY's ROE of +0.02%. Regarding short-term risk, ERFSF is more volatile compared to HNGZY. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs VIMGF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, VIMGF has a market cap of 2.3B. Regarding current trading prices, ERFSF is priced at $71.01, while VIMGF trades at $4.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas VIMGF's P/E ratio is 90.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to VIMGF's ROE of +0.03%. Regarding short-term risk, ERFSF is more volatile compared to VIMGF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs MRCHF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, MRCHF has a market cap of 1.3B. Regarding current trading prices, ERFSF is priced at $71.01, while MRCHF trades at $22.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas MRCHF's P/E ratio is 68.39. In terms of profitability, ERFSF's ROE is +0.07%, compared to MRCHF's ROE of -0.04%. Regarding short-term risk, ERFSF is more volatile compared to MRCHF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs CORBF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, CORBF has a market cap of 200.9M. Regarding current trading prices, ERFSF is priced at $71.01, while CORBF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas CORBF's P/E ratio is 3.57. In terms of profitability, ERFSF's ROE is +0.07%, compared to CORBF's ROE of +0.11%. Regarding short-term risk, ERFSF is more volatile compared to CORBF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs AMCY Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, AMCY has a market cap of 171.3M. Regarding current trading prices, ERFSF is priced at $71.01, while AMCY trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas AMCY's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to AMCY's ROE of N/A. Regarding short-term risk, ERFSF is more volatile compared to AMCY. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs EDTXF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, EDTXF has a market cap of 167M. Regarding current trading prices, ERFSF is priced at $71.01, while EDTXF trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas EDTXF's P/E ratio is -9.76. In terms of profitability, ERFSF's ROE is +0.07%, compared to EDTXF's ROE of +0.79%. Regarding short-term risk, ERFSF is more volatile compared to EDTXF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs IDGXF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, IDGXF has a market cap of 164.5M. Regarding current trading prices, ERFSF is priced at $71.01, while IDGXF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas IDGXF's P/E ratio is 7.07. In terms of profitability, ERFSF's ROE is +0.07%, compared to IDGXF's ROE of +0.24%. Regarding short-term risk, ERFSF is more volatile compared to IDGXF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs NNGRF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, NNGRF has a market cap of 164.3M. Regarding current trading prices, ERFSF is priced at $71.01, while NNGRF trades at $12.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas NNGRF's P/E ratio is 60.75. In terms of profitability, ERFSF's ROE is +0.07%, compared to NNGRF's ROE of -0.07%. Regarding short-term risk, ERFSF is more volatile compared to NNGRF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs THOXF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, THOXF has a market cap of 130.9M. Regarding current trading prices, ERFSF is priced at $71.01, while THOXF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas THOXF's P/E ratio is -14.40. In terms of profitability, ERFSF's ROE is +0.07%, compared to THOXF's ROE of -0.91%. Regarding short-term risk, ERFSF is more volatile compared to THOXF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs DIUXF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, DIUXF has a market cap of 115.5M. Regarding current trading prices, ERFSF is priced at $71.01, while DIUXF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas DIUXF's P/E ratio is 136.72. In terms of profitability, ERFSF's ROE is +0.07%, compared to DIUXF's ROE of -0.07%. Regarding short-term risk, ERFSF is more volatile compared to DIUXF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs TIHE Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, TIHE has a market cap of 71.9M. Regarding current trading prices, ERFSF is priced at $71.01, while TIHE trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas TIHE's P/E ratio is 0.32. In terms of profitability, ERFSF's ROE is +0.07%, compared to TIHE's ROE of +0.01%. Regarding short-term risk, ERFSF is more volatile compared to TIHE. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs BIOGF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, BIOGF has a market cap of 65.4M. Regarding current trading prices, ERFSF is priced at $71.01, while BIOGF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas BIOGF's P/E ratio is -0.67. In terms of profitability, ERFSF's ROE is +0.07%, compared to BIOGF's ROE of +2.04%. Regarding short-term risk, ERFSF is more volatile compared to BIOGF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs PFGTF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, PFGTF has a market cap of 65M. Regarding current trading prices, ERFSF is priced at $71.01, while PFGTF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas PFGTF's P/E ratio is -4.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to PFGTF's ROE of -0.41%. Regarding short-term risk, ERFSF is more volatile compared to PFGTF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs PCNEF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, PCNEF has a market cap of 62M. Regarding current trading prices, ERFSF is priced at $71.01, while PCNEF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas PCNEF's P/E ratio is -8.44. In terms of profitability, ERFSF's ROE is +0.07%, compared to PCNEF's ROE of -0.21%. Regarding short-term risk, ERFSF is more volatile compared to PCNEF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs CLIFF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, CLIFF has a market cap of 44.1M. Regarding current trading prices, ERFSF is priced at $71.01, while CLIFF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas CLIFF's P/E ratio is -2.87. In terms of profitability, ERFSF's ROE is +0.07%, compared to CLIFF's ROE of -0.08%. Regarding short-term risk, ERFSF is more volatile compared to CLIFF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs BIOQ Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, BIOQ has a market cap of 43.4M. Regarding current trading prices, ERFSF is priced at $71.01, while BIOQ trades at $44.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas BIOQ's P/E ratio is 17.42. In terms of profitability, ERFSF's ROE is +0.07%, compared to BIOQ's ROE of -0.06%. Regarding short-term risk, ERFSF is more volatile compared to BIOQ. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs SNANF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, SNANF has a market cap of 41.2M. Regarding current trading prices, ERFSF is priced at $71.01, while SNANF trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas SNANF's P/E ratio is -19.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to SNANF's ROE of -2.51%. Regarding short-term risk, ERFSF is more volatile compared to SNANF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs ANPCF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, ANPCF has a market cap of 34.2M. Regarding current trading prices, ERFSF is priced at $71.01, while ANPCF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas ANPCF's P/E ratio is -1.06. In terms of profitability, ERFSF's ROE is +0.07%, compared to ANPCF's ROE of -0.54%. Regarding short-term risk, ERFSF is more volatile compared to ANPCF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs ANPCY Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, ANPCY has a market cap of 29.3M. Regarding current trading prices, ERFSF is priced at $71.01, while ANPCY trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas ANPCY's P/E ratio is -1.40. In terms of profitability, ERFSF's ROE is +0.07%, compared to ANPCY's ROE of -0.75%. Regarding short-term risk, ERFSF is more volatile compared to ANPCY. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs IMMVF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, IMMVF has a market cap of 22.6M. Regarding current trading prices, ERFSF is priced at $71.01, while IMMVF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas IMMVF's P/E ratio is -0.32. In terms of profitability, ERFSF's ROE is +0.07%, compared to IMMVF's ROE of -2.69%. Regarding short-term risk, ERFSF is more volatile compared to IMMVF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs PCHM Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, PCHM has a market cap of 22.4M. Regarding current trading prices, ERFSF is priced at $71.01, while PCHM trades at $3.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas PCHM's P/E ratio is -0.02. In terms of profitability, ERFSF's ROE is +0.07%, compared to PCHM's ROE of +0.53%. Regarding short-term risk, ERFSF is more volatile compared to PCHM. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs VILGF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, VILGF has a market cap of 20.7M. Regarding current trading prices, ERFSF is priced at $71.01, while VILGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas VILGF's P/E ratio is -0.30. In terms of profitability, ERFSF's ROE is +0.07%, compared to VILGF's ROE of N/A. Regarding short-term risk, ERFSF is more volatile compared to VILGF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs LDXHF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, LDXHF has a market cap of 19.5M. Regarding current trading prices, ERFSF is priced at $71.01, while LDXHF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas LDXHF's P/E ratio is -2.60. In terms of profitability, ERFSF's ROE is +0.07%, compared to LDXHF's ROE of -1.38%. Regarding short-term risk, ERFSF is more volatile compared to LDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs BMKDF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, BMKDF has a market cap of 18.5M. Regarding current trading prices, ERFSF is priced at $71.01, while BMKDF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas BMKDF's P/E ratio is -20.34. In terms of profitability, ERFSF's ROE is +0.07%, compared to BMKDF's ROE of +2.24%. Regarding short-term risk, ERFSF is more volatile compared to BMKDF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs ABDXF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, ABDXF has a market cap of 13.6M. Regarding current trading prices, ERFSF is priced at $71.01, while ABDXF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas ABDXF's P/E ratio is -1.40. In terms of profitability, ERFSF's ROE is +0.07%, compared to ABDXF's ROE of -0.63%. Regarding short-term risk, ERFSF is more volatile compared to ABDXF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs JMPHF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, JMPHF has a market cap of 13.4M. Regarding current trading prices, ERFSF is priced at $71.01, while JMPHF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas JMPHF's P/E ratio is -2.91. In terms of profitability, ERFSF's ROE is +0.07%, compared to JMPHF's ROE of -0.11%. Regarding short-term risk, ERFSF is more volatile compared to JMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs PMSNF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, PMSNF has a market cap of 13.3M. Regarding current trading prices, ERFSF is priced at $71.01, while PMSNF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas PMSNF's P/E ratio is -2.24. In terms of profitability, ERFSF's ROE is +0.07%, compared to PMSNF's ROE of +0.69%. Regarding short-term risk, ERFSF is more volatile compared to PMSNF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs IZOZF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, IZOZF has a market cap of 10.9M. Regarding current trading prices, ERFSF is priced at $71.01, while IZOZF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas IZOZF's P/E ratio is -6.01. In terms of profitability, ERFSF's ROE is +0.07%, compared to IZOZF's ROE of +0.47%. Regarding short-term risk, ERFSF is less volatile compared to IZOZF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs MXDHF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, MXDHF has a market cap of 8.6M. Regarding current trading prices, ERFSF is priced at $71.01, while MXDHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas MXDHF's P/E ratio is -0.12. In terms of profitability, ERFSF's ROE is +0.07%, compared to MXDHF's ROE of -5.35%. Regarding short-term risk, ERFSF is more volatile compared to MXDHF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs VRCDF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, VRCDF has a market cap of 7.3M. Regarding current trading prices, ERFSF is priced at $71.01, while VRCDF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas VRCDF's P/E ratio is -1.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to VRCDF's ROE of -0.73%. Regarding short-term risk, ERFSF is more volatile compared to VRCDF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs TDSGF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, TDSGF has a market cap of 6.2M. Regarding current trading prices, ERFSF is priced at $71.01, while TDSGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas TDSGF's P/E ratio is -3.07. In terms of profitability, ERFSF's ROE is +0.07%, compared to TDSGF's ROE of -3.19%. Regarding short-term risk, ERFSF is more volatile compared to TDSGF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs SQIDF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, SQIDF has a market cap of 6.1M. Regarding current trading prices, ERFSF is priced at $71.01, while SQIDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas SQIDF's P/E ratio is -0.37. In terms of profitability, ERFSF's ROE is +0.07%, compared to SQIDF's ROE of +4.47%. Regarding short-term risk, ERFSF is less volatile compared to SQIDF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs IBXXF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, IBXXF has a market cap of 4.8M. Regarding current trading prices, ERFSF is priced at $71.01, while IBXXF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas IBXXF's P/E ratio is -0.80. In terms of profitability, ERFSF's ROE is +0.07%, compared to IBXXF's ROE of +0.55%. Regarding short-term risk, ERFSF is more volatile compared to IBXXF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs SLDX Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, SLDX has a market cap of 4.5M. Regarding current trading prices, ERFSF is priced at $71.01, while SLDX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas SLDX's P/E ratio is -0.01. In terms of profitability, ERFSF's ROE is +0.07%, compared to SLDX's ROE of +0.06%. Regarding short-term risk, ERFSF is more volatile compared to SLDX. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs GNTLF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, GNTLF has a market cap of 3.7M. Regarding current trading prices, ERFSF is priced at $71.01, while GNTLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas GNTLF's P/E ratio is -16.67. In terms of profitability, ERFSF's ROE is +0.07%, compared to GNTLF's ROE of -3.62%. Regarding short-term risk, ERFSF is more volatile compared to GNTLF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs IDXG Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, IDXG has a market cap of 3.3M. Regarding current trading prices, ERFSF is priced at $71.01, while IDXG trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas IDXG's P/E ratio is 2.70. In terms of profitability, ERFSF's ROE is +0.07%, compared to IDXG's ROE of -1.19%. Regarding short-term risk, ERFSF is more volatile compared to IDXG. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs SZLSF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, SZLSF has a market cap of 3M. Regarding current trading prices, ERFSF is priced at $71.01, while SZLSF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas SZLSF's P/E ratio is -0.20. In terms of profitability, ERFSF's ROE is +0.07%, compared to SZLSF's ROE of +0.13%. Regarding short-term risk, ERFSF is less volatile compared to SZLSF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs AVCRF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, AVCRF has a market cap of 2.9M. Regarding current trading prices, ERFSF is priced at $71.01, while AVCRF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas AVCRF's P/E ratio is -2.87. In terms of profitability, ERFSF's ROE is +0.07%, compared to AVCRF's ROE of +0.05%. Regarding short-term risk, ERFSF is more volatile compared to AVCRF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs ICBU Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, ICBU has a market cap of 2.3M. Regarding current trading prices, ERFSF is priced at $71.01, while ICBU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas ICBU's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to ICBU's ROE of +0.70%. Regarding short-term risk, ERFSF is less volatile compared to ICBU. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs IVRO Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, IVRO has a market cap of 1.5M. Regarding current trading prices, ERFSF is priced at $71.01, while IVRO trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas IVRO's P/E ratio is -0.81. In terms of profitability, ERFSF's ROE is +0.07%, compared to IVRO's ROE of +0.08%. Regarding short-term risk, ERFSF is more volatile compared to IVRO. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs IDTA Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, IDTA has a market cap of 1.1M. Regarding current trading prices, ERFSF is priced at $71.01, while IDTA trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas IDTA's P/E ratio is 2.81. In terms of profitability, ERFSF's ROE is +0.07%, compared to IDTA's ROE of +0.36%. Regarding short-term risk, ERFSF is more volatile compared to IDTA. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs DIGP Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, DIGP has a market cap of 1.1M. Regarding current trading prices, ERFSF is priced at $71.01, while DIGP trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas DIGP's P/E ratio is -1.04. In terms of profitability, ERFSF's ROE is +0.07%, compared to DIGP's ROE of +3.08%. Regarding short-term risk, ERFSF is less volatile compared to DIGP. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs NSTM Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, NSTM has a market cap of 1.1M. Regarding current trading prices, ERFSF is priced at $71.01, while NSTM trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas NSTM's P/E ratio is -0.38. In terms of profitability, ERFSF's ROE is +0.07%, compared to NSTM's ROE of +0.87%. Regarding short-term risk, ERFSF is more volatile compared to NSTM. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs SCRSF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, SCRSF has a market cap of 903.9K. Regarding current trading prices, ERFSF is priced at $71.01, while SCRSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas SCRSF's P/E ratio is -0.09. In terms of profitability, ERFSF's ROE is +0.07%, compared to SCRSF's ROE of +2.91%. Regarding short-term risk, ERFSF is more volatile compared to SCRSF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs EPGNF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, EPGNF has a market cap of 692.4K. Regarding current trading prices, ERFSF is priced at $71.01, while EPGNF trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas EPGNF's P/E ratio is -0.04. In terms of profitability, ERFSF's ROE is +0.07%, compared to EPGNF's ROE of -4.14%. Regarding short-term risk, ERFSF is more volatile compared to EPGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs MBGNF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, MBGNF has a market cap of 172.6K. Regarding current trading prices, ERFSF is priced at $71.01, while MBGNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas MBGNF's P/E ratio is -1.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to MBGNF's ROE of +0.37%. Regarding short-term risk, ERFSF is more volatile compared to MBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs NVTAQ Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, NVTAQ has a market cap of 85.9K. Regarding current trading prices, ERFSF is priced at $71.01, while NVTAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas NVTAQ's P/E ratio is -0.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to NVTAQ's ROE of +0.00%. Regarding short-term risk, ERFSF is less volatile compared to NVTAQ. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs ARYC Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, ARYC has a market cap of 79.3K. Regarding current trading prices, ERFSF is priced at $71.01, while ARYC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas ARYC's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to ARYC's ROE of +0.55%. Regarding short-term risk, ERFSF is more volatile compared to ARYC. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs HCLC Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, HCLC has a market cap of 74K. Regarding current trading prices, ERFSF is priced at $71.01, while HCLC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas HCLC's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to HCLC's ROE of +0.11%. Regarding short-term risk, ERFSF is more volatile compared to HCLC. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs MEDVF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, MEDVF has a market cap of 54K. Regarding current trading prices, ERFSF is priced at $71.01, while MEDVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas MEDVF's P/E ratio is -0.03. In terms of profitability, ERFSF's ROE is +0.07%, compared to MEDVF's ROE of +0.57%. Regarding short-term risk, ERFSF is more volatile compared to MEDVF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs RNVA Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, RNVA has a market cap of 43.1K. Regarding current trading prices, ERFSF is priced at $71.01, while RNVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas RNVA's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to RNVA's ROE of +0.23%. Regarding short-term risk, ERFSF is more volatile compared to RNVA. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs CHHL Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, CHHL has a market cap of 37.3K. Regarding current trading prices, ERFSF is priced at $71.01, while CHHL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas CHHL's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to CHHL's ROE of +0.00%. Regarding short-term risk, ERFSF is more volatile compared to CHHL. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs IHTI Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, IHTI has a market cap of 32.5K. Regarding current trading prices, ERFSF is priced at $71.01, while IHTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas IHTI's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to IHTI's ROE of +0.00%. Regarding short-term risk, ERFSF is more volatile compared to IHTI. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs MEDD Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, MEDD has a market cap of 31.9K. Regarding current trading prices, ERFSF is priced at $71.01, while MEDD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas MEDD's P/E ratio is -0.01. In terms of profitability, ERFSF's ROE is +0.07%, compared to MEDD's ROE of +0.74%. Regarding short-term risk, ERFSF is more volatile compared to MEDD. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs CGNH Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, CGNH has a market cap of 12K. Regarding current trading prices, ERFSF is priced at $71.01, while CGNH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas CGNH's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to CGNH's ROE of +1.41%. Regarding short-term risk, ERFSF is more volatile compared to CGNH. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs RSHN Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, RSHN has a market cap of 8.2K. Regarding current trading prices, ERFSF is priced at $71.01, while RSHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas RSHN's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to RSHN's ROE of -5.42%. Regarding short-term risk, ERFSF is more volatile compared to RSHN. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs ABMC Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, ABMC has a market cap of 4.8K. Regarding current trading prices, ERFSF is priced at $71.01, while ABMC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas ABMC's P/E ratio is 0.01. In terms of profitability, ERFSF's ROE is +0.07%, compared to ABMC's ROE of +0.86%. Regarding short-term risk, ERFSF is more volatile compared to ABMC. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs RGDXQ Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, RGDXQ has a market cap of 3.9K. Regarding current trading prices, ERFSF is priced at $71.01, while RGDXQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas RGDXQ's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to RGDXQ's ROE of -1.27%. Regarding short-term risk, ERFSF is more volatile compared to RGDXQ. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs DMTKQ Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, DMTKQ has a market cap of 3.5K. Regarding current trading prices, ERFSF is priced at $71.01, while DMTKQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas DMTKQ's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to DMTKQ's ROE of -0.80%. Regarding short-term risk, ERFSF is more volatile compared to DMTKQ. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs TOMDF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, TOMDF has a market cap of 1.4K. Regarding current trading prices, ERFSF is priced at $71.01, while TOMDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas TOMDF's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to TOMDF's ROE of +0.84%. Regarding short-term risk, ERFSF is more volatile compared to TOMDF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs GWHP Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, GWHP has a market cap of 1.3K. Regarding current trading prices, ERFSF is priced at $71.01, while GWHP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas GWHP's P/E ratio is -0.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to GWHP's ROE of +0.00%. Regarding short-term risk, ERFSF is less volatile compared to GWHP. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs CYPS Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, CYPS has a market cap of 811. Regarding current trading prices, ERFSF is priced at $71.01, while CYPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas CYPS's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to CYPS's ROE of N/A. Regarding short-term risk, ERFSF is more volatile compared to CYPS. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs ROSGQ Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, ROSGQ has a market cap of 593. Regarding current trading prices, ERFSF is priced at $71.01, while ROSGQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas ROSGQ's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to ROSGQ's ROE of -1.35%. Regarding short-term risk, ERFSF is more volatile compared to ROSGQ. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs BIOCQ Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, BIOCQ has a market cap of 263. Regarding current trading prices, ERFSF is priced at $71.01, while BIOCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas BIOCQ's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to BIOCQ's ROE of -1.38%. Regarding short-term risk, ERFSF is more volatile compared to BIOCQ. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs HTGMQ Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, HTGMQ has a market cap of 221. Regarding current trading prices, ERFSF is priced at $71.01, while HTGMQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas HTGMQ's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to HTGMQ's ROE of -2.73%. Regarding short-term risk, ERFSF is more volatile compared to HTGMQ. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs OPGX Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, OPGX has a market cap of 17. Regarding current trading prices, ERFSF is priced at $71.01, while OPGX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas OPGX's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to OPGX's ROE of +0.46%. Regarding short-term risk, ERFSF is more volatile compared to OPGX. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs AGHC Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, AGHC has a market cap of 0. Regarding current trading prices, ERFSF is priced at $71.01, while AGHC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas AGHC's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to AGHC's ROE of +2.90%. Regarding short-term risk, ERFSF is more volatile compared to AGHC. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs MRPS Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, MRPS has a market cap of 0. Regarding current trading prices, ERFSF is priced at $71.01, while MRPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas MRPS's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to MRPS's ROE of N/A. Regarding short-term risk, ERFSF is more volatile compared to MRPS. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs BGNX Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, BGNX has a market cap of 0. Regarding current trading prices, ERFSF is priced at $71.01, while BGNX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas BGNX's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to BGNX's ROE of N/A. Regarding short-term risk, ERFSF is more volatile compared to BGNX. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs EPGNY Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 12.9B. In comparison, EPGNY has a market cap of 0. Regarding current trading prices, ERFSF is priced at $71.01, while EPGNY trades at $2.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 30.43, whereas EPGNY's P/E ratio is -1.60. In terms of profitability, ERFSF's ROE is +0.07%, compared to EPGNY's ROE of -0.19%. Regarding short-term risk, ERFSF is more volatile compared to EPGNY. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.